Risk factor profile of Mucormycosis in COVID 19 patients: A Case series
Coronavirus disease-19 (COVID-19)-infected patients are at risk to develop severe opportunistic infections, especially fungal infections. The incidence of mucormycosis has increased in patients who are recovering from COVID-19 and now it has become an epidemic in India. In the background of the COVI...
Main Authors: | Rahul Soni, Dheeraj Nauhwaar, Abhinav Kumar, Ankita Patil, Manish Saha, Jayita Debnath |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Journal of Marine Medical Society |
Subjects: | |
Online Access: | http://www.marinemedicalsociety.in/article.asp?issn=0975-3605;year=2021;volume=23;issue=2;spage=219;epage=224;aulast=Soni |
Similar Items
-
A case of invasive pulmonary mucormycosis resulting from short courses of corticosteroids in a well-controlled diabetic patient
by: Kathy Hoang, et al.
Published: (2020-09-01) -
Post COVID-19 mucormycosis: A case series
by: Mala Vinod Kaneria, et al.
Published: (2021-01-01) -
Mucormycosis in COVID-19
by: Vasantha Kamath, et al.
Published: (2021-01-01) -
Clinical, laboratory and radiological assessment of patients with COVID-19 associated mucormycosis (CAM) along with their management profile: an observational study
by: A. Soni, et al.
Published: (2022-06-01) -
Factors Associated with Mortality in Coronavirus-Associated Mucormycosis: Results from Mycotic Infections in COVID-19 (MUNCO) Online Registry
by: Shitij Arora, et al.
Published: (2022-11-01)